Abstract |
A two-centre intra-individual crossover study was performed in 23 patients with suspected high-grade glioma or metastases to assess and compare the safety and enhancement characteristics of two different MRI contrast media ( gadobenate dimeglumine, Gd-BOPTA and gadoterate meglumine, Gd-DOTA) at equivalent doses of 0.1 mmol/kg body weight. T1-weighted spin-echo (SE) and T2-weighted fast SE images were obtained before and T1-weighted images 0, 2, 4, 6, 8 and 15 min after injection. T1-weighted images with magnetisation transfer contrast were acquired 12 min after injection. Qualitative assessment by blinded, off-site readers (reader 1:19 patients; reader 2:21) and on-site investigators (23) revealed significant (P< or =0.005) overall preference for Gd-BOPTA over Gd-DOTA for contrast enhancement ( Gd-BOPTA preferred in 18, 15 and 18 cases; Gd-DOTA in 0, 1 and 1 and no preference in 1, 5 and 4; off-site readers 1 and 2, and on-site investigators, respectively). A similar significant preference for Gd-BOPTA was expressed by off-site readers and on-site investigators for lesion-to-brain contrast, lesion delineation, internal lesion structure, and overall image preference. Quantitative assessment by off-site readers revealed significantly (p<0.05) greater lesion enhancement with Gd-BOPTA than with Gd-DOTA at all times from 2 min after injection.
|
Authors | C Colosimo, M V Knopp, X Barreau, E Gérardin, M A Kirchin, F Guézénoc, K P Lodemann |
Journal | Neuroradiology
(Neuroradiology)
Vol. 46
Issue 8
Pg. 655-65
(Aug 2004)
ISSN: 0028-3940 [Print] Germany |
PMID | 15205859
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Contrast Media
- Heterocyclic Compounds
- Organometallic Compounds
- gadobenic acid
- Meglumine
- gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
|
Topics |
- Aged
- Brain Neoplasms
(pathology, secondary)
- Contrast Media
- Cross-Over Studies
- Double-Blind Method
- Female
- Glioma
(pathology)
- Heterocyclic Compounds
- Humans
- Magnetic Resonance Imaging
- Male
- Meglumine
(analogs & derivatives)
- Middle Aged
- Organometallic Compounds
- Sensitivity and Specificity
|